Market revenue in 2023 | USD 6.3 million |
Market revenue in 2030 | USD 10.7 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.57% in 2023. Horizon Databook has segmented the Colombia clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Colombia offers various benefits to life sciences companies such as pharmaceutical, biotech, and Med Tech companies to enhance quality and ethical clinical research at a competitive cost.
There are various associated advantages for conducting clinical trials in Colombia such as 30% to 50% cost-saving in clinical trials in comparison with the U.S. and Europe and access to around 50 million patients.
Therefore, various CROs in the country offer clinical trial services to end users such as pharmaceutical and biotech companies. Bio access is a CRO that offers services for conducting early-stage clinical trial by life sciences companies in Colombia.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Colombia clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account